Adhami v. The Cooper Companies, Inc et al
| VIOLA ADHAMI |
| Teva Women's Health LLC doing business as Teva Women's Health Inc, Teva Pharmaceuticals USA Inc, Teva Women's Health LLC, The Cooper Companies Inc, Coopersurgical Inc, Duramed Pharmaceuticals Inc A Division of Barr Pharmaceuticals, Inc. doing business as Teva Women's Health Inc and Teva Women's Health Inc |
| 1:2021cv00303 |
| January 19, 2021 |
| US District Court for the Northern District of Georgia |
| Leigh Martin May |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 18, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 44
ORDER in case 1:20-md-02974-LMM granting #39 Motion to Appoint Lead Counsel. Frederick M. Erny and Gina M. Saelinger Appointed as lead counsel for defendants. See document for further specifics. Signed by Judge Leigh Martin May on 2/18/2021. Associated Cases: 1:20-md-02974-LMM et al.(tmf)
|
|
Filing 43
ORDER in case 1:20-md-02974-LMM granting #38 Motion to Appoint Lead Counsel. Erin K Copeland and Timothy Clark Appointed as lead counsel for plaintiffs. See document for further specifics. Signed by Judge Leigh Martin May on 2/18/2021. Associated Cases: 1:20-md-02974-LMM et al.(tmf)
|
| Filing 42 Clerk's Certificate of Mailing re 34 ORDER INITIAL CONFERENCE (as to attached list). Associated Cases: 1:20-md-02974-LMM et al.(tmf) |
|
Filing 41
ORDER INITIAL CONFERENCE: The Court held its Initial Conference in this MDL on February 9, 2021. The below are the orders entered after discussion of these issues at that conference. 1. Leadership structure: After the Court discussed issues concerning the leadership structure with all parties, the Court ORDERED Plaintiffs and Defendants to each file their proposed consent motion and order as to their requested leadership structure and team within 7 days of the date of this order. 2. Future status conferences: The Court will hold status conferences once a month. The next six conferences will take place on the following dates at 10:00 am via zoom: Tuesday, March 9, 2021; Monday, April 12, 2021; Wednesday, May 12, 2021; Monday, June 14, 2021; Tuesday, July 13, 2021; Friday, August 20, 2021. The Court will send out the zoom links prior to the conferences. The parties will submit a proposed consent agenda 3 business days prior to the conference. The parties will also confer as to the format for presenting issues that require additional explanation. When these are necessary, they should also be filed 3 business days before the conference. 3. Stay of responsive pleading obligations: The Court continues the stay of responsive pleading obligations provided for in Section 6(b) of the Court's initial order. 4. Pending motions: The Court DENIES WITHOUT PREJUDICE all pending motions in the individual cases comprising the MDL. These cases are also ADMINISTRATIVELY CLOSED. These terminated motions will later be refiled in accordance with an upcoming Case Management Order. 5. Docketing: All parties are to docket future filings only in the MDL case. The case caption should indicate whether any filing applies to all cases or list the individual cases to which it should apply. 6. Electronic service: The Court ORDERS all attorneys participating in the MDL proceeding to register with the Court's CM/ECF system. Because all attorneys will then receive electronic copies of documents filed in the MDL, the Court ORDERS that electronic service of documents via the Court's CM/ECF system satisfies the obligation of service. Hereafter, unless otherwise ordered, neither the clerk's office nor counsel for the parties shall be obligated to provide service copies of any filings or related orders by U.S. Mail or any other means to attorneys who have not registered with the Court's CM/ECF system. An attorney who is not participating in the MDL and does not want to receive CM/ECF notifications may file a motion to withdraw or a certificate of consent to withdraw in accordance with Local Rule 83.1(E). 7. Initial disclosures: The Court GRANTS the parties' joint request for the Court to excuse the parties from Rule 26(f) initial disclosures; except as to the ParaGard New Drug Application (NDA) that was transferred on or about November 10, 2005, to Duramed Pharmaceuticals, Inc., and produced by TWH, Inc., to plaintiff in the Estrada case. 8. Case management and initial orders: The parties are ORDERED to confer as to proposed orders for the list found herein. See order for further specifics and instructions. Signed by Judge Leigh Martin May on 2/10/2021. Associated Cases: 1:20-md-02974-LMM et al.(tmf)
|
| Civil Case Terminated. (bdb) |
| Filing 40 AGENDA INITIAL CONFERENCE: Herein is the Court's agenda for the February 9, 2021, meeting. The format of the meeting will be collaborative and additional items may be discussed as needed. Zoom Meeting Link for Initial Conference: https://ganduscourts.zoomgov.com/j/1606612652 Meeting ID: 160 661 2652; Passcode: 123456; Dial by your location: +1 669 254 5252 US (San Jose); +1 646 828 7666 US (New York); +1 551 285 1373 US; +1 669 216 1590 US (San Jose). Signed by Judge Leigh Martin May on 2/8/2021. Associated Cases: 1:20-md-02974-LMM et al.(tmf) |
| Filing 39 Mail sent to Timothy M. Clark re #37 Order Returned as Undeliverable. Marked: Return to sender, attempted-not known, unable to forward. (jpk) |
| Filing 38 Mail sent to Lauren A. Welling re #37 Order Returned as Undeliverable. Marked: Return to sender, attempted-not known, unable to forward. (jpk) |
|
Filing 37
PRACTICE AND PROCEDURE ORDER AND NOTICE OF INITIAL CONFERENCE: The Court will hold the initial case management conference via videoconference on February 9, 2021, at 10:00 a.m. (instructions found herein). Counsel will submit to the Court by January 25, 2021, a brief consolidated written statement indicating their preliminary understanding of the facts involved in the litigation and the critical factual and legal issues. Counsel will submit to the Court by January 25, 2021, a list of all companies affiliated with the parties and all counsel associated in the litigation. After the initial conference, all attorneys participating in these cases will be required to be registered with the Court's CM/ECF system. See order for further specifics and instructions. Signed by Judge Leigh Martin May on 1/7/2021. (tmf) Modified on 1/22/2021 to modify file date of order to date case was transferred in(rvb).
|
|
Filing 36
NINTH GENERAL ORDER IN RE: COURT OPERATIONS UNDER THE EXIGENT CIRCUMSTANCES CREATED BY COVID-19 AND RELATED CORONAVIRUS Signed by Judge Thomas W. Thrash, Jr. on 12/08/2020. (aar)
|
| Filing 35 Case transferred in from District of Massachusetts; Case Number 1:20-cv-12051. Original file certified copy of transfer order and docket sheet received. |
| Filing 34 Case Electronically transferred to the Northern District of Georgia pursuant to Conditional Transfer Order entered by the MDL Panel on 12/29/2020. (Currie, Haley) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 33 Certified copy of MDL Conditional Transfer Order number CTO-1 in MDL Case 2974 received from Northern District of Georgia requesting transfer of case for consolidated pretrial proceedings. (Currie, Haley) [Transferred from Massachusetts on 1/19/2021.] |
| Clerk's Certificate of Mailing as to BRIAN RUBENSTEIN, Kara D Hill, Lauren A. Welling, Matthew J. Lynch, Timothy M. Clark, and Tobias Millrood re #37 Order. (tmf) |
|
Filing 37
PRACTICE AND PROCEDURE ORDER AND NOTICE OF INITIAL CONFERENCE: The Court will hold the initial case management conference via videoconference on February 9, 2021, at 10:00 a.m. (instructions found herein). Counsel will submit to the Court by January 25, 2021, a brief consolidated written statement indicating their preliminary understanding of the facts involved in the litigation and the critical factual and legal issues. Counsel will submit to the Court by January 25, 2021, a list of all companies affiliated with the parties and all counsel associated in the litigation. After the initial conference, all attorneys participating in these cases will be required to be registered with the Court's CM/ECF system. See order for further specifics and instructions. Signed by Judge Leigh Martin May on 1/7/2021. (tmf)
|
| Filing 32 ELECTRONIC NOTICE Canceling Hearing. In light of the Conditional Transfer Order to N.D. Ga, D. 31, the Court cancels the scheduling conference scheduled for 1/7/21 in this district, D. 20. (Hourihan, Lisa) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 31 Informational copy of MDL Conditional Transfer Order number 1 in MDL Case 2974 received from of the mdl panel requesting transfer of case for consolidated pretrial proceedings. (Jones, Sherry) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 30 NOTICE of Appearance by Matthew J. Lynch on behalf of Teva Women's Health LLC (Lynch, Matthew) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 29 NOTICE of Appearance by Emily G. Coughlin on behalf of The Cooper Companies, Inc. (Coughlin, Emily) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 28 NOTICE of Appearance by Emily G. Coughlin on behalf of Coopersurgical, Inc. (Coughlin, Emily) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 27 NOTICE of Appearance by Emily G. Coughlin on behalf of Teva Women's Health, Inc. (Coughlin, Emily) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 26 NOTICE of Appearance by Emily G. Coughlin on behalf of Teva Pharmaceuticals USA Inc (Coughlin, Emily) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 25 NOTICE of Appearance by Emily G. Coughlin on behalf of Teva Women's Health LLC (Coughlin, Emily) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 24 NOTICE of Appearance by Matthew J. Lynch on behalf of Coopersurgical, Inc. (Lynch, Matthew) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 23 NOTICE of Appearance by Matthew J. Lynch on behalf of The Cooper Companies, Inc. (Lynch, Matthew) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 22 NOTICE of Appearance by Matthew J. Lynch on behalf of Teva Women's Health, Inc. (Lynch, Matthew) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 21 NOTICE of Appearance by Matthew J. Lynch on behalf of Teva Pharmaceuticals USA Inc (Lynch, Matthew) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 20 ELECTRONIC NOTICE OF RESCHEDULINGThis hearing will be conducted by video conference. Counsel of record will receive a video conference invite at the email registered in CM/ECF. If you have technical or compatibility issues with the technology, please notify the session's courtroom deputy as soon as possible.Access to the hearing will be made available to the media and public. In order to gain access to the hearing, you must sign up at the following address: #https://forms.mad.uscourts.gov/courtlist.html. For questions regarding access to hearings, you may refer to the Court's general orders and public notices available on #www.mad.uscourts.gov or contact media@mad.uscourts.gov. Scheduling Conference set for 1/7/2021 02:30 PM in Remote Proceeding : Boston before Judge Denise J. Casper. (Hourihan, Lisa) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 19 Judge Denise J. Casper: ORDER entered. Standing Order Re: Courtroom Opportunities for Relatively Inexperienced Attorneys(Hourihan, Lisa) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 18 Judge Denise J. Casper: Standing Order Regarding Appearance of Counsel Via Telephone or Videoconference (Hourihan, Lisa) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 17 NOTICE of Scheduling Conference Scheduling Conference set for 12/14/2020 02:30 PM in Remote Proceeding : Boston before Judge Denise J. Casper. This hearing will be conducted by video conference. Counsel of record will receive a video conference invite at the email registered in CM/ECF. If you have technical or compatibility issues with the technology, please notify the sessions courtroom deputy as soon as possible.Access to the hearing will be made available to the media and public. In order to gain access to the hearing, you must sign up at the following address: #www.public.mad.uscourts.gov/seating-signup. For questions regarding access to hearings, you may refer to the Courts general orders and public notices available on #www.mad.uscourts.gov or contact media@mad.uscourts.gov.(Hourihan, Lisa) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 16 ELECTRONIC NOTICE of Case Assignment. Judge Denise J. Casper assigned to case. If the trial Judge issues an Order of Reference of any matter in this case to a Magistrate Judge, the matter will be transmitted to Magistrate Judge Jennifer C. Boal. (Danieli, Chris) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 15 Case transferred in from District of Pennsylvania Eastern; Case Number 2:20-cv-05060. [Transferred from Massachusetts on 1/19/2021.] |
|
Filing 14
ORDER THAT THIS ACTION IS TRANSFERRED PURSUANT TO 28 USC SEC. 1404(a) TO UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MASSACHUSETTS. SIGNED BY HONORABLE HARVEY BARTLE, III ON 11/12/20. 11/12/20 ENTERED & E-MAILED.(fdc) [Transferred from Massachusetts on 1/19/2021.]
|
| Filing 13 NOTICE of Appearance by RANDI KASSAN on behalf of VIOLA ADHAMI (KASSAN, RANDI) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 12 Original Record together with certified copy of docket entries received from Court of Common Pleas of PHILADELPHIA County. (JL ) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 11 ANSWER to Complaint by COOPERSURGICAL, INC..(RUBENSTEIN, BRIAN) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 10 ANSWER to Complaint by THE COOPER COMPANIES, INC.(RUBENSTEIN, BRIAN) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 9 ANSWER to Complaint by TEVA WOMEN'S HEALTH LLC f/k/a Teva Women's Health, Inc..(RUBENSTEIN, BRIAN) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 8 ANSWER to Complaint by TEVA WOMEN'S HEALTH, INC. INDIVIDUALLY, AND AS SUCCESSOR IN INTEREST TO, DURAMED PHARMACEUTICALS, INC., A DIVISON OF BARR PHARMACEUTICALS, INC..(RUBENSTEIN, BRIAN) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 7 ANSWER to Complaint by TEVA PHARMACEUTICALS USA, INC..(RUBENSTEIN, BRIAN) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 6 Disclosure Statement Form pursuant to FRCP 7.1 including TEVA PHARMACEUTICAL INDUSTRIES LTD. by TEVA WOMEN'S HEALTH LLC f/k/a Teva Women's Health, Inc..(RUBENSTEIN, BRIAN) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 5 Disclosure Statement Form pursuant to FRCP 7.1 including TEVA PHARMACEUTICAL INDUSTRIES LTD. by TEVA WOMEN'S HEALTH, INC. INDIVIDUALLY, AND AS SUCCESSOR IN INTEREST TO, DURAMED PHARMACEUTICALS, INC., A DIVISON OF BARR PHARMACEUTICALS, INC..(RUBENSTEIN, BRIAN) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 4 Disclosure Statement Form pursuant to FRCP 7.1 including TEVA PHARMACEUTICAL INDUSTRIES LTD. by TEVA PHARMACEUTICALS USA, INC..(RUBENSTEIN, BRIAN) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 3 Disclosure Statement Form pursuant to FRCP 7.1 including THE COOPER COMPANIES, INC. by COOPERSURGICAL, INC..(RUBENSTEIN, BRIAN) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 2 Disclosure Statement Form pursuant to FRCP 7.1 including VANGUARD GROUP, INC. by THE COOPER COMPANIES, INC.(RUBENSTEIN, BRIAN) [Transferred from Massachusetts on 1/19/2021.] |
| Filing 1 NOTICE OF REMOVAL by THE COOPER COMPANIES, INC, TEVA WOMEN'S HEALTH, INC. INDIVIDUALLY, AND AS SUCCESSOR IN INTEREST TO, DURAMED PHARMACEUTICALS, INC., A DIVISON OF BARR PHARMACEUTICALS, INC., DURAMED PHARMACEUTICALS, INC. A DIVISION OF BARR PHARMACEUTICALS, INC. D/B/A TEVA WOMEN'S HEALTH, INC., TEVA WOMEN'S HEALTH, LLC, INDIVIDUALLY AND AS SUCCESSOR IN INTEREST TO TEVA WOMEN'S HEALTH, INC., COOPERSURGICAL, INC., TEVA PHARMACEUTICALS USA, INC., TEVA WOMEN'S HEALTH LLC f/k/a Teva Women's Health, Inc. (Filing fee $ 400 receipt number 0313-14632895), filed by THE COOPER COMPANIES, INC, TEVA WOMEN'S HEALTH, INC. INDIVIDUALLY, AND AS SUCCESSOR IN INTEREST TO, DURAMED PHARMACEUTICALS, INC., A DIVISON OF BARR PHARMACEUTICALS, INC., DURAMED PHARMACEUTICALS, INC. A DIVISION OF BARR PHARMACEUTICALS, INC. D/B/A TEVA WOMEN'S HEALTH, INC., TEVA WOMEN'S HEALTH, LLC, INDIVIDUALLY AND AS SUCCESSOR IN INTEREST TO TEVA WOMEN'S HEALTH, INC., COOPERSURGICAL, INC., TEVA PHARMACEUTICALS USA, INC., TEVA WOMEN'S HEALTH LLC f/k/a Teva Women's Health, Inc..(RUBENSTEIN, BRIAN) [Transferred from Massachusetts on 1/19/2021.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Georgia Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
